With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

2014 Session Topics:
I. Bridging Genomics & Proteomics in Cancer
II. Cancer Biomarkers in Discovery & Clinical Trials
III. Emerging Cancer Targets & Therapeutic Strategies
         - Kinse Inhibitors
         - Epigenetic Regulators
         - Metabolic Pathways
         - Cancer Stem Cells
IV. Progress in Cancer Immunotherapy
V. Combination Strategies in Immuno-Oncology
VI. Clinical Drug Development

This conference is part of our larger Novel Cancer Therapeutics Summit 2014, which includes one additional parallel conference:

Novel Cancer Therapeutics Summit 2014:

• 2nd Oncology Partnering & Deal-Making
• 4th Cancer Targets & Therapeutics